What Doctors Don't Tell YouHopes of finding healthy women to test tamoxifen, the breast cancer drug, have taken a further blow following a new study from Scotland. ...
New evidence from the Netherlands shows that long term tamoxifen use increases the risk of endometrial cancers with a poor prognosis. ...
There is growing evidence that those proposing to prescribe the drug tamoxifen as a preventative measure to women supposedly at high risk of breast cancer are simply trading one form of the diseas ...
The breast cancer drug tamoxifen-marketed in the UK as Emblon, Noltam and Tamofen, and as Nolvadex in the US and the UK-has been enjoying some favourable press comment recently. ...
American drug regulators look like opening the floodgates on the use of the breast cancer drug tamoxifen. It is about to be licensed in the US as a preventative and there's a good chance the UK m ...
The reputation of the breast cancer drug tamoxifen has taken another serious knock following the publication of two European trials that show it is not a cancer preventative. ...
This month, the instructive case study about terrible doctoring comes from my own back yard. ...
New evidence from two studies show that women who take tamoxifen to prevent or treat breast cancer are at greater risk of endometrial abnormalities, including cancer. ...
Recently, you probably saw the newspaper articles about "new fears" raised by tamoxifen, the drug used to prevent and treat breast cancer. The stories concerned a Dutch case control study publish ...
Women who take tamoxifen to prevent breast cancer are getting too much of the drug, according to new evidence. ...
